Renal Denervation Devices Market Analysis-2020

1. RENAL DENERVATION DEVICES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Renal Denervation Devices Market- Overview Renal Denervation Devices Market - Global Forecast to 2026, by Product Type (Simplicity Renal Denervation System, Vessix Renal denervation System, EnligHTN, Paradise Renal Denervation System, Iberis Renal sympathetic Denervation System, and Others), by Technology (Radiofrequency and Ultrasound), by End user (Hospitals, Ambulatory Surgical Centers, Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026 Renal denervation devices is an advanced device used in the treatment of hypertension. Basically, it is a catheter-based therapy in which catheters is inserted into the renal artery to delivers radio-frequency energy in order to ablate the nerves in the vessel wall that control vasoconstriction. This opens the vessels permanently to facilitate greater blood flow to the kidneys. The global renal denervation devices market size was valued at US$ 88.6 million in 2017 and is expected to exhibit a CAGR of 35.5% over the forecast period (2018 – 2026). Rising prevalence of hypertension is projected to propel the growth of the renal denervation devices market Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/renal- denervation-devices-market-798 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Increasing prevalence of cardiovascular diseases (CVDs) and hypertension is projected to fuel demand for renal denervation devices around the globe. For instance, according to the World Health Organization (WHO), the prevalence of hypertension in adults aged 25 and above was around 40% in 2008 worldwide. According to the American College of Cardiology (ACC)/the American Heart Association (AHA), the clinical practice guidelines of hypertension have modified the definition of hypertension, which has increased the prevalence of hypertension to 45.6% or around 103.3 million people in the U.S. in 2017. Furthermore, according to WHO 2017, Africa accounts for the highest number of high blood pressure cases worldwide, affecting around 46% of adults, due to increasing urbanization and unhealthy lifestyles. According to the Blood Pressure Association in the U.K., the highest number of people suffering from high blood pressure was recorded in South Asia and parts of Africa, where over 50% of those with high blood pressure lived in the Asia Pacific, including 226 million people in China and 199 million in India in 2015. Therefore, a growing number of high blood pressure cases are projected to boost the market growth. For instance, according to the American College of Cardiology (ACC)/American Heart Association (AHA), the number of people adopting pharmaceutical therapy increased by 13.9 million (from 24.0 in 2013 % to 54.4% of the treated patients) in the U.S. in 2017. Moreover, around 30 million people in China choose pharmaceutical treatment for hypertension in 2017. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/798 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The rising number of research and development activities and regulatory approvals in Europe is projected to bolster the market growth Europe holds a dominant position in the global renal denervation device market, and this can be attributed to rising research and development activities and regulatory approvals. For instance, in February 2014, Cordis Corporation, a division of Johnson & Johnson, received CE Mark for Renlane renal denervation system. The system consists of a unique, helical shaped, irrigated, a multi-electrode ablation catheter with a multi-channel radiofrequency (RF) ablation system. Moreover, a growing number of clinical trials on renal denervation devices is also projected to boost market growth. For instance, multi-center, international, single-blind, randomized, sham- controlled clinical trials of RADIANCE-HTN SOLO were conducted at 21 centers in the U.S. and 18 in Europe. The trials meet primary efficacy endpoints, according to an announcement by ReCor Medical in May 2018. Key Players Major players operating in the global renal denervation device market include St. Jude Medical, Inc., ReCor Medical Inc., Boston Scientific Corporation, Cardiosonic Ltd, Medtronic Plc., Kona Medical, Inc., Mercator Medsystems, Inc., Terumo Corporation, Abbott Laboratories, and Theragenics Corporation. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/798 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved